No additional risk of breast cancer recurrence with TNF inhibitors

Breast cancer survivors receiving TNF inhibitors for rheumatoid arthritis are not at an increased risk of their cancer recurring compared to those receiving other medicines. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. It is more common in older people, and affects both men and women. […]

Read More…